StonvexLoading…
StonvexCore line items from TEM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-31 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $385.05M | $348.12M | $1.27B | $904.58M | $570.37M |
Operating Income | Not available | $-84.71M | $-252.87M | $-191.46M | $-130.46M |
Net Income | Not available | $-125.92M | $-245.03M | $-190.86M | $-110.88M |
EPS (Diluted) | $-0.13 | $-0.71 | $-1.41 | $-1.10 | $-0.64 |
Total Assets | Not available | $2.14B | $2.27B | $2.28B | $1.63B |
Total Liabilities | Not available | $1.72B | $1.78B | $1.77B | $1.32B |
Cash & Equivalents | Not available | $521.17M | $604.79M | $655.92M | $186.31M |
Free Cash Flow OCF − CapEx | Not available | $-81.48M | $-239.14M | $-197.60M | $-71.05M |
Shares Outstanding | Not available | 178.96K | 174.26K | 172.97K | 171.96K |